These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12107041)

  • 41. The current situation of treatment systems for alcoholism in Korea.
    Kim JW; Lee BC; Kang TC; Choi IG
    J Korean Med Sci; 2013 Feb; 28(2):181-9. PubMed ID: 23400047
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cost and cost-effectiveness of the COMBINE study in alcohol-dependent patients.
    Zarkin GA; Bray JW; Aldridge A; Mitra D; Mills MJ; Couper DJ; Cisler RA;
    Arch Gen Psychiatry; 2008 Oct; 65(10):1214-21. PubMed ID: 18838638
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Testing combined pharmacotherapies and behavioral interventions in alcohol dependence: rationale and methods.
    COMBINE Study Research Group
    Alcohol Clin Exp Res; 2003 Jul; 27(7):1107-22. PubMed ID: 12878917
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of acamprosate on magnetic resonance spectroscopy measures of central glutamate in detoxified alcohol-dependent individuals: a randomized controlled experimental medicine study.
    Umhau JC; Momenan R; Schwandt ML; Singley E; Lifshitz M; Doty L; Adams LJ; Vengeliene V; Spanagel R; Zhang Y; Shen J; George DT; Hommer D; Heilig M
    Arch Gen Psychiatry; 2010 Oct; 67(10):1069-77. PubMed ID: 20921123
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation.
    Mason BJ; Goodman AM; Chabac S; Lehert P
    J Psychiatr Res; 2006 Aug; 40(5):383-93. PubMed ID: 16546214
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A randomized, multicentre, open-label, comparative trial of disulfiram, naltrexone and acamprosate in the treatment of alcohol dependence.
    Laaksonen E; Koski-Jännes A; Salaspuro M; Ahtinen H; Alho H
    Alcohol Alcohol; 2008; 43(1):53-61. PubMed ID: 17965444
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combining medical treatment and CBT in treating alcohol-dependent patients: effects on life quality and general well-being.
    Laaksonen E; Vuoristo-Myllys S; Koski-Jannes A; Alho H
    Alcohol Alcohol; 2013; 48(6):687-93. PubMed ID: 23813295
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acamprosate for alcohol dependence.
    Rösner S; Hackl-Herrwerth A; Leucht S; Lehert P; Vecchi S; Soyka M
    Cochrane Database Syst Rev; 2010 Sep; (9):CD004332. PubMed ID: 20824837
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of acamprosate and placebo in long-term treatment of alcohol dependence.
    Whitworth AB; Fischer F; Lesch OM; Nimmerrichter A; Oberbauer H; Platz T; Potgieter A; Walter H; Fleischhacker WW
    Lancet; 1996 May; 347(9013):1438-42. PubMed ID: 8676626
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acamprosate supports abstinence, naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes.
    Rösner S; Leucht S; Lehert P; Soyka M
    J Psychopharmacol; 2008 Jan; 22(1):11-23. PubMed ID: 18187529
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review.
    Bouza C; Angeles M; Muñoz A; Amate JM
    Addiction; 2004 Jul; 99(7):811-28. PubMed ID: 15200577
    [TBL] [Abstract][Full Text] [Related]  

  • 52. National trends in alcohol pharmacotherapy: Findings from an Australian claims database.
    Morley KC; Logge W; Pearson SA; Baillie A; Haber PS
    Drug Alcohol Depend; 2016 Sep; 166():254-7. PubMed ID: 27394934
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New therapies for alcohol problems: application to primary care.
    Fiellin DA; Reid MC; O'Connor PG
    Am J Med; 2000 Feb; 108(3):227-37. PubMed ID: 10723977
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acamprosate in alcohol dependence: a randomized controlled efficacy study in a standard clinical setting.
    Baltieri DA; De Andrade AG
    J Stud Alcohol; 2004 Jan; 65(1):136-9. PubMed ID: 15000513
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Urinary ethyl glucuronide and ethyl sulfate testing for recent drinking in alcohol-dependent outpatients treated with acamprosate or placebo.
    Dahl H; Hammarberg A; Franck J; Helander A
    Alcohol Alcohol; 2011; 46(5):553-7. PubMed ID: 21616946
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effects of current subsyndromal psychiatric symptoms or past psychopathology on alcohol dependence treatment outcomes and acamprosate efficacy.
    Mason BJ; Lehert P
    Am J Addict; 2010; 19(2):147-54. PubMed ID: 20163387
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acamprosate during and after acute alcohol withdrawal: a double-blind placebo-controlled study in Spain.
    Gual A; Lehert P
    Alcohol Alcohol; 2001; 36(5):413-8. PubMed ID: 11524307
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The European NEAT program: an integrated approach using acamprosate and psychosocial support for the prevention of relapse in alcohol-dependent patients with a statistical modeling of therapy success prediction.
    Pelc I; Ansoms C; Lehert P; Fischer F; Fuchs WJ; Landron F; Pires Preto AJ; Morgan MY
    Alcohol Clin Exp Res; 2002 Oct; 26(10):1529-38. PubMed ID: 12394286
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acamprosate: a prototypic neuromodulator in the treatment of alcohol dependence.
    Mason BJ; Heyser CJ
    CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):23-32. PubMed ID: 20201812
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effectiveness of Psychoanalytic-Interactional Group Therapy vs. Behavioral Group Therapy in Routine Outpatient Treatment of Alcohol-Dependent Patients.
    Nyhuis PW; Niederhofer E; Scherbaum N; Schifano F; Bonnet U; Dembski N; Niederhofer A; Specka M; Tenbergen M
    Subst Use Misuse; 2018 Feb; 53(3):426-431. PubMed ID: 29016275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.